Orbis Research has announced the addition of the “Women's Health Cluster
Drug Development Pipeline Review, 2017”
to store by company, by country, and by application/type for the competitive
landscape analysis.
This report
provides an overview of the women’s health pipeline landscape. The report
provides comprehensive information on the therapeutics under development and
key players involved in therapeutic development for female infertility,
polycystic ovarian syndrome and endometriosis, and also features dormant and
discontinued projects.Get the request a sample of ‘ Women's Health Cluster Drug Development Pipeline Review, 2017’ report
Scope
- Which companies are the most active within the pipeline for women’s health therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of women’s health therapeutics?
The size of these pipelines ranges
from 12 in PCOS to 87 in female infertility. The most common types of therapy
being developed in these diseases act on hormone receptors, reflecting the
hormone-driven pathophysiology of this disease area. However, particularly in
polycystic ovarian syndrome, a broader range of molecular targets, such as
intracellular protein kinases, chemokine receptors and other cell signaling
components are also targeted.
Browse the
complete report @ http://www.orbisresearch.com/reports/index/womens-health-cluster-drug-development-pipeline-review-2017 .The three key disorders covered in this report are largely driven by dysfunction of the endocrine system, but have a broad range of effects. Infertility is defined as the inability to get pregnant after a year of unprotected intercourse. Female infertility can be also be caused by a number of factors, which include damage to fallopian tubes, hormonal causes, cervical causes, uterine causes, unexplained infertility. Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair on the scalp, weight gain, excess androgen and polycystic ovaries. Finally, endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (the endometrium) grows outside the uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding.
Get the discount of this report @ http://www.orbisresearch.com/contacts/discount/289235 .
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 () 884-6817; +912064101019
Email ID: sales@orbisresearch.com
